OPCML and ovarian cancer: When AXL is complexed with its ligand GAS6 in ovarian cancer cells, OPCML chaperones the AXL-GAS6 complex into external membrane lipid-raft domains where the complex becomes dephosphorylated through apposition to a raft restricted phosphatase and then targeted for ubiquitin-dependent degradation [9,12].